Leukaemia-resistant C57BL/6 mice inoculated with the Friend complex (FLC) present a transient but definite depression of the ability to develop IgM and IgG antibody-producing cells to sheep red cells (SRC). In this paper it is shown that this immunodepression cannot be attributed solely to the lymphatic leukaemia virus (LLV) component of FLC which is immunodepressive in susceptible mice. This conclusion was reached by investigating the immunological reactivity of C57BL/6 mice following inoculation with two isolates of LLV. Circumstantial evidence obtained by examining the replication of FLC and LLV, the antibody response to E. eoli lipopolysaccharide (LPS) and the ability of syngeneic macrophages administered together with the antigen to restore the response to SRC points to the same conclusion. There were also indications that the low sensitivity to depression by viruses of the Friend complex exhibited by the anti-LPS antibody response is due to the mitogenic activity of this antigen.
INTRODUCTION
Following inoculation with the Friend leukaemia complex (FLC), adult C57BL/6 mice do not exhibit the syndrome characterized by a rapid evolving hepatosplenomegaly with erythroleukaemia as typically seen in susceptible strains and may only present a short lived splenomegaly of moderate degree (Stutman & Dupuy, 1972) . Nevertheless it has repeatedly been reported that FLC infection of C57BL/6 mice results in a transient but definite depression of the antibody response to sheep red cells (SRC) (Schneider & Dor~, ~969;  Ceglowski et al. I974, I975; Kumar et al. 1974) .
The resistance of C57BL/6 mice to the leukaemogenic activity of FLC is accompanied by, and is probably due to, a restriction in virus replication since of the two entities that form FLC, the lymphatic leukaemia virus (LLV) and the erythroleukaemia-inducing component, only the former can replicate in this strain (Axelrad & Van Der Gaag, 1968; Steeves & Eckner, I97o; Lilly & Pincus, 1973 ). Here we show that, contrary to what might be expected on the basis of the differential permissiveness of C57BL/6 mice for the FLC components, the depression of antibody responsiveness observed in these mice after inoculation with FLC cannot be attributed solely to the LLV component. In addition, we show that the antibody response to bacterial lipopolysaccharide (LPS) in both susceptible and resistant mice is less affected by the viruses of the FLC than the response to SRC and present evidence suggesting that this is due to the mitogenic properties of the former antigen.
METHODS
Animals. C57BL/6 and BALB/c mice bred in this Institute by brother-sister mating and aged 8 to I2 weeks were used. Animals homogeneous in age and sex were randomly assigned to the experimental groups. Each group consisted of 7 to io mice.
Viruses. Details of the preparation and titration of the viruses were given in a previous paper (Bendinelli & Nardini, I973) . FLC, anaemia-inducing strain, was obtained from the plasma of adult BALB/c mice and contained between lo a'° and Io 4"° IDs0 per o.i ml in different batches. The Rowson-Parr isolate of LLV (RP-LLV) was obtained from the plasma of BALB/c mice either infected at birth (titre Io 4"~ to ro ~° IDs0 per o-~ ml) or as adults (titre IO z'5 to Io 3.0 IDa0 per o.I ml) but no differences were observed between the effects of different preparations. The passage histories of FLC and RP-LLV (Pendinelli, I97I) indicate that they are NB tropic. Mice were injected intravenously with o.I ml of virus preparations.
Virus testing in the spleen of infected mice. For in vitro assay, o.2 ml of Io % spleen extract were added to Falcon dishes (6 cm in diam.) containing 1.6 x Io n S+L -ceils grown in McCoy's 5a medium supplemented with ~o% foetal calf serum for 24 h at 37 °C, and pretreated with 25 #g/ml DEAE-dextran for 2o rain (Bassin et al. I971) . The medium was replaced 2 days later and the cells were stained with amido black after an additional 2 days incubation. Foci of transformed cells were counted at low magnification. This method detects LLV only.
For in vivo assay, groups of 3 to 4 BALB/c mice were injected intravenously with o.2 ml of the spleen extract and their spleens were weighed 3 weeks later. Spleen weights exceeding 5o0 mg were taken as evidence of FLC infection (Bendinelli & Nardini, I973) .
Antigens. SRC were obtained from a single donor, stored in Alsever's solution and washed three times before use. Escherichia coli oI27:B8 LPS prepared according to Westphal (Difco Laboratories, Detroit, Michigan, U.S.A.) was dissolved in phosphate buffered saline (PBS) at a concentration of I mg/ml, boiled for I h and stored at -7o °C. Alkali-treated LPS (AIk-LPS) was prepared by the method of Niwa et al. (I969) and stored as above. In a dose-response test (incorporation of 3H-thymidine by spleen cells of C57BL/6 mice into acid-insoluble material after z days in vitro) Alk-LPS was devoid of mitogenic activity at concentrations up to loo#g/ml, whereas LPS was active at concentrations as low as o-I #g/ml.
Unless otherwise stated, mice were immunized intravenously with io 8 SRC in o'4 ml of saline or with IO #g of LPS in o'4 ml of PBS.
Antibody-forming cell assay. The number of plaque-forming cells (PFC) in the spleen was determined by the method of Jerne using SRC or LPS-coated SRC (Watson & Riblet, I974) as test antigen. Indirect PFC to SRC were developed with rabbit anti-mouse Ig serum (Pentex, Kankakee, Illinois, U.S.A.). Unless otherwise stated, the assay was carried out 4 days after SRC immunization or 6 days after LPS and Alk-LPS immunization. For each spleen a minimum of two plates were prepared and the mean counts were recorded. In calculating the anti-LPS response, the PFC produced against SRC were subtracted from those produced against LPS-coated SRC. The geometric means of PFC per spleen are given, together with 95 % confidence limits of the geometric mean. Student's t test was used to compare the difference between means.
Peritoneal exudate cells. Peritoneal exudate cells (PEC) were harvested with 5 ml of Eagle's minimum essential medium containing 5 i.u. heparin/ml 5 days after intraperitoneal inoculation with 2 ml of 2 % proteose peptone (Difco) in saline. The cells were washed once with medium, viability tested by trypan blue exclusion, resuspended in medium at the concentration required and mixed with the immunizing dose of SRC immediately before intravenous inoculation.
RESULTS

Antibody response to SRC in FLC-or RP-LL V-infected C57BL/6 mice
Fig . I shows the effects of FLC on the 4-day splenic PFC response to SRC of C57BL/6 mice. When 3 days elapsed between FLC inoculation and immunization direct PFC were reduced Io-fold (P < o.ooi) and indirect PFC fourfold (P < o'oo0, while with a 6-day interval direct PFC were reduced threefold (P < o'oo5) and indirect PFC twofold (P < o.o2). In contrast, when the interval between virus and antigen inoculation was IO or more days there was little, if any, effect on the PFC response.
In Fig. 2 the kinetics of the PFC response to SRC of uninfected and infected mice are compared. Mice which were inoculated with virus 3 days before immunization exhibited reduced numbers of both direct and indirect PFC at all times, whereas mice given FLC io days before the antigen had normal or near normal levels of PFC at all times except on day I I post-immunization when they showed significantly fewer indirect PFC (P < o.oo5).
The immunodepression produced by FLC in C57BL/6 mice is reminiscent of that characterizing the immunodepression produced by RP-LLV in BALB/c mice (Carter et al. I97o; Beudinelli, I973) . However, RP-LLV given at various times before immunization had no detectable effects on the anti-SRC PFC response of C57BL/6 mice to SRC (data not shown). This failure to depress the antibody response of C57BL/6 mice to SRC was repeatedly observed using various batches of RP-LLV prepared in adult or newborn BALB/c mice and possessing different virus titres and also employing a different isolate of LLV obtained by passaging the polycythaemia-inducing strain of FLC through newborn C57BL/6 mice (Steeves et al. I97I) .
Virus content in the spleen of FLC-or RP-LLV-infected C57BL/6 mice
The virus content in the spleen of C57BL/6 mice was evaluated at various times after infection by assaying extracts for focus formation in S+L -cells and for the ability to induce spleuomegaly in BALB/c mice. The first test detects LLV (Bassinet al. I97 I) while the second makes it possible to distinguish between FLC and LLV due to the different degree of splenomegaly produced 3 weeks after infection (Bendinelli & Nardini, I973)-The assay was carried out 4, 7, IO, I4 and 25 days after virus inoculation, but infectivity was detected only in the extracts prepared from 4 day-infected mice. At this time LLV was detected both in FLC-and RP-LLV-infected mice, but its titre was constantly low, ranging between io and Iooo focus forming units per spleen in different experiments. The in vivo assay showed that in the FLC-infected mice a low level of FLC activity was also present.
Effect of peritoneal exudate cells (PEC) on the antibody response to SRC of FLC-infected C57BL/6 and BALB/c mice Previous results
showed that the antibody response to SRC of BALB/c mice infected with RP-LLV can be restored by administering small numbers of syngeneic PEC together with the antigen (Bendinelli et al. I976) . As shown in Table t , the depression of antibody response to SRC produced by FLC was not reversed by this treatment in either C57BL/6 or BALB/c mice.
Antibody response to LPS in FLC-and RP-LLV-infected C57BL/6
and BALB/c mice Experiment I in Table z shows that both FLC and RP-LLV impaired the anti-LPS response of BALB/c mice, although in different ways. In keeping with previous results (Hirano et al. I969) , FLC given I, 3 or 6 days before the antigen depressed the anti-LPS PFC counts (P < o'oo0. When the interval between FLC infection and immunization was further increased the depression was more pronounced (data not presented), though never reaching the levels observed in the response to SRC (Wedderburn & Salaman, I968). RP-LLV induced a transient depression of lower degree that reached statistical significance only when the interval between infection and immunization was 6 days (P < o.oz). Experiments 2 and 3 in Table 2 show that, in contrast, C57BL/6 mice inoculated with FLC or RP-LLV produced normal numbers of PFC regardless of the time interval between virus inoculation and immunization.
Antibody response to Alk-LPS in FLC-infected C57BL/6 mice
Moderate alkaline hydrolysis has been shown to destroy the mitogenicity of LPS without abolishing its immunogenicity and antigenic specificity (Poe & Michael, x976; Von Eschen & Rudbach, D76) . C57BL/6 mice were immunized with AIk-LPS 3 days after FLC infection and the numbers of PFC detected in their spleens using LPS-coated SRC were compared with those produced by uninfected animals. Table 3 shows that infected mice immunized with ~o or Ioo #g of Alk-LPS produced significantly reduced PFC responses (P < o.o2 and < o'o5 respectively). Table 4 presents the effects of administering LPS simultaneously with the antigen on the PFC response to SRC. The depressed responses to the standard antigen dose exhibited by BALB/c mice infected with FLC or RP-LLV, and by C57BL/6 mice infected with FLC, were all potentiated by LPS, though to a different extent. In experiment 2, LPS brought the response of FLC-infected C57BL/6 mice to levels not significantly different from those of * The results are expressed as defined in Table I ; 8 mice per group. the uninfected groups treated with the corresponding dose of LPS. In experiment 2, the response of FLC-infected BALB/c mice was virtually unaffected by IOO #g of LPS and only slightly enhanced by 3 °/zg of LPS. In experiment 3, consistent with previous findings (Bendinelli et al. ~976) , the administration of LPS (30 or IOO/zg) to RP-LLV-infected BALB/c mice markedly potentiated the response which, however, remained lower than that of the uninfected groups treated with LPS (P < o'oo0. The suppressive effect of RP-LLV on the antibody response to SRC can be partially reversed also by increasing antigen dosage (Bendinelli, ~973) . In experiment 4, the effects of LPS on the anti-SRC response of RP-LLV-infected BALB/c mice immunized with ten times the standard SRC dose were investigated. LPS potentiated the response of the uninfected controls, but did not affect the reactivity of infected animals.
Effect of LPS on the antibody response to SRC in FLC-or RP-LLV-infected C57BL/6 and BALB/c mice
In all the above experiments the spleen weight increase caused by LPS was generally moderate in both infected and uninfected mice and was not strictly correlated with the degree of enhancement of the antibody response, making it unlikely that the latter effect was merely due to a generalized augmentation of spleen cellularity.
DISCUSSION
Host resistance to the replication and the pathological activity of the erythroleukaemiainducing component of FLC is controlled by the Fv-2 locus with two alleles, one for susceptibility (Fv-2 ~) and one for resistance (Fv-20. Susceptibility to LLV is not influenced by the Fv-2 gene but is governed by the Fv-I gene with at least two alleles, Fv-i n and Fv-I b. Fv-I n homozygotes are permissive for the growth of the N-and NB-tropic strains of LLV and relatively resistant to the B-tropic strains, whereas animals possessing the homozygous Fv-~ b genotype are permissive for B-and NB-tropic viruses and relatively resistant to N-tropic strains (Lilly & Pincus, ~973) .
With this information, it is not surprising that the immunodepression exerted by NBtropic strains of FLC in C57BL/6 mice, a strain with genetic constitution Fv-2 ~r and Fv-~ bb, has been tentatively attributed to LLV (Kumar et al. I974; Ceglowski et al. I975) which in susceptible BALB/c mice is known to produce an immunological impairment similar to that observed in the early stages of infection with the entire complex (Carter et al. ~97o; Steeves et al. I97i ; 13endinelli & Nardini, r973) . Analogies between the effects of FLC on the immune functions of C57BL/6 mice and those of LLV in BALB/c mice favoured this interpretation.
The present experiments demonstrate that, in contrast to expectation, LLV fails to reproduce the immunodepression exerted in leukaemia-resistant mice by the entire complex. C57BL/6 mice inoculated with RP-LLV at various times before immunization constantly developed normal PFC responses to SRC, whereas following injection with the anaemiainducing strain of FLC from which RP-LLV was originally obtained (Rowson & Parr, I97o) , they exhibited a suppression of this response with extent and duration comparable to that previously observed using the polycythaemia-inducing strain of FLC (Ceglowski et al. x975) . A different isolate of LLV also failed to depress the PFC responsiveness of C57BL/6 mice.
A contribution of the erythroleukaemia component to the immunological impairment produced in C57BL/6 mice by FLC has to be postulated. It is hoped that experiments presently in progress will allow the isolation of the erythroleukaemia component free of LLV, thus permitting us to test this thesis directly. However, the data on the presence of virus in the spleen of infected C57BL/6 mice are in keeping with this conclusion. After inoculation with both FLC and RP-LLV, infectious virus could only be recovered for a short time and at low titre, but in the spleen of FLC-infected animals, in addition to LLV, a small amount of the erythroleukaemia component was present and it may be significant that the period during which the latter entity was detectable coincided with the time of maximum immunodepression. The erythroleukaemia component might provoke a transient activation of suppressor cells (Kumar et al. I976) or produce an abortive infection of lymphoid ceils incompatible with a normal immunological reactivity. Alternatively, it might facilitate the activity of LLV. In an attempt to test the latter possibility we measured the anti-SRC response of C57BL/6 mice injected with a mixture of inactivated FLC and fully active RP-LLV, but we were unable to detect a significant immunodepression (unpublished results).
The administration of syngeneic macrophages together with the antigen reconstitutes the antibody response to SRC of LLV-infected BALB/c mice (Bendinelli et aL t976) . Thus, the present finding that the immunodepression induced by FLC in C57BL/6 mice is as refractory to this treatment as that induced in susceptible mice is additional evidence that the immunological impairment brought about by FLC in resistant mice is not due solely to LLV. The experiments in which LPS was used to monitor the immunological reactivity may point to the same conclusion when they show that the response to this antigen is not depressed by FLC in resistant mice, though reduced by RP-LLV in susceptible mice.
A feature that the present data share with previous results (Hirano et al. I969 ) is the lower sensitivity of the antibody response against LPS to depression by the viruses of the FLC as compared to the response toward SRC. The antibody response to LPS differs from the response to SRC in that it is much less dependent on T cells and macrophages (Andersson & Blongren, I97I; Poe & Michael, I974) and this limited cell requirement might explain its resistance to the depressive activity of FLC. The radiation leukaemia virus in C57BL/6 mice has been shown to depress the response to thymus-dependent but not to thymusindependent antigens I974) . However, LPS is also a strong B cell mitogen and this property might contribute to its ability to evoke a normal antibody response in immunodepressed mice. A role for mitogenicity is indicated by the fact that the simultaneous injection of SRC and LPS may completely restore the anti-SRC response of infected mice and by the finding that FLC-infected C57BL/6 mice exhibit a depressed antibody response to Alk-LPS, an antigen which is devoid of mitogenic properties (Niwa et al. I969; Poe & Michael, i976; Von Eschen & Rudbach, I976 ) . It is noteworthy that LPS has been shown to overcome other immunodepressive states which might involve oncornaviruses (Roder et al. I976; Roman & Golub, 1976) .
Taken together the present results suggest that the mechanisms whereby FLC and its LLV component immunodepress are partially different and that the mode of action by which FLC immunodepresses leukaemia-susceptible and resistant mice is also different. Thus FLC would appear to behave like the radiation leukaemia virus which affects different immunocompetent cell types in different mouse strains (Shearer et al. I973; I974) .
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